Register
Medicines reference
Product

Artrin

Glucosamine + Chondroitin sulfate + Manganese · Brouwer S.A.

1 form: scored tablet. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Enter weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
500/100/10 mg palatable scored tablets, Scored tablet · Dog under 15 kg Dog under 15 kg Degenerative Joint Disease · oral: 1/2 tablet - Georgia Yes, veterinary
In force until 14 Jul 2030
Veterinary (National Food Agency)
In the register: ართრინი
№ 000894
Verified on: 21 Oct 2026
500/100/10 mg palatable scored tablets, Scored tablet · Dog 15 kg and over Dog 15 kg and over Degenerative Joint Disease · oral: 1 tablet - Georgia Yes, veterinary
In force until 14 Jul 2030
Veterinary (National Food Agency)
In the register: ართრინი
№ 000894
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Artrin 500/100/10 mg palatable scored tablets, Scored tablet

N30 for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.7/10
Weak evidence support
vetman assessment

Artrin

500/100/10 mg palatable scored tablets, N30 for dogs
Assessed clinical scopeDog · Full dog label: glucosamine, chondroitin sulfate and manganese chewable tablets as joint support in degenerative joint disease and osteoarthritis · oral
Care settingLong-term home use as an optional add-on to weight control, exercise management and proven analgesia
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000894 · Verified on 21 Oct 2026

A weak option: a joint-support product with little proof of benefit and limited exact-product safety evidence. Base osteoarthritis care on weight control, exercise and proven analgesics such as NSAIDs.

Regulatory and scientific credibility4.0/10

The N30 dog presentation is registered in Georgia (000894, valid to 2030) with the Argentine maker's leaflet, but no EU, UK or US authorisation was documented in the reviewed evidence or product study, and claims rest on manufacturer material.

Clinical efficacy3.0/10

Systematic reviews and pain guidelines find weak or inconsistent evidence that glucosamine and chondroitin improve pain or function in canine osteoarthritis; a fixed one tablet above 15 kg also gives large dogs a low dose per kg.

Safety and tolerability6.0/10

The manufacturer leaflet lists pregnancy, lactation and phenylketonuria exclusions and possible antibiotic-absorption interactions, but no exact-product tolerability study or quantified adverse-event dataset was found.

Clinical practicality6.5/10

A palatable scored tablet once daily (half below 15 kg, one above) for at least 6 weeks is easy, but the leaflet leaves exactly 15 kg unassigned.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use during pregnancy or lactation, in phenylketonuria or with hypersensitivity to a component.
  • Glucosamine can increase tetracycline absorption and reduce chloramphenicol and penicillin absorption.
  • Not an analgesic: dogs with osteoarthritis pain need proven pain control.
  • One tablet is the dose for every dog above 15 kg, so large dogs get a low dose per kg; no dose is set for exactly 15 kg.
  • Judge response after the minimum 6-week course and stop if there is no clear benefit.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Glucosamine500 mg/tablet Chondroitin sulfate100 mg/tablet Manganese10 mg/tablet
Formulation Type
Scored tablet
Administration route
oral
Manufacturer
Brouwer S.A. · Argentina
Manufacturer (register)
BROUWER S.A., Argentina
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1438, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 14 Jul 2030
Veterinary (National Food Agency)
In the register: ართრინი
№ 000894
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
Dog
WeightDegenerative Joint Disease · oral
under 15 kg 1/2 tablet
15 kg and over 1 tablet
  • Degenerative Joint Disease · oral (once daily; minimum course 6 weeks): The Georgian NFA presentation is for DOGS ONLY, so no cat dose is staged. Give one half tablet daily below 15 kg. The leaflet leaves exactly 15 kg unassigned; no dose is inferred there. Do not use with component hypersensitivity or phenylketonuria, or during pregnancy or lactation. Glucosamine can increase tetracycline absorption and reduce chloramphenicol and penicillin absorption. Stop and seek veterinary advice after suspected overdose or intolerance.
Source:
Brouwer label
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Artrin - veterinary product leaflet
Brouwer veterinary product leaflet

Glucosamine: No dose supported by a publicly verifiable source yet

Chondroitin sulfate: No dose supported by a publicly verifiable source yet

Manganese: No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.